Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ginsenoside Rb1 attenuates activated microglia-induced neuronal damage.
MS patients must have access to the best treatment options.
Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.
There is still a role for the blink reflex in the diagnosis and follow-up of multiple sclerosis.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria.
Albumin heterogeneity in low-abundance fluids. The case of urine and cerebro-spinal fluid.
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.
Costs and quality of life in multiple sclerosis patients with spasticity.
Neuroinflammation: no rose by any other name.
Multiple sclerosis guideline production takes off.
Walking Speed and Brain Glucose Uptake are Uncoupled in Patients with Multiple Sclerosis.
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
In vitro myelin formation using embryonic stem cells.
Restoring nervous system structure and function using tissue engineered living scaffolds.
Pathological differences between white and grey matter multiple sclerosis lesions.
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
Longitudinally extensive transverse myelitis associated with amphiphysin autoimmunity and breast cancer: a paraneoplastic accompaniment.
NLRP3 inflammasome and its inhibitors: a review.
Current topics in therapeutic plasmapheresis.
Pediatric demyelinating diseases.
Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury.
Superficial brain stimulation in multiple sclerosis.
Diabetes insipidus as a rare cause of acute cognitive impairment in multiple sclerosis.
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report.
Pages
« first
‹ previous
…
579
580
581
582
583
584
585
586
587
…
next ›
last »